Quote | Mountain Crest Acquisition Corp. II (NASDAQ:MCAD)
Last: | $10.43 |
---|---|
Change Percent: | -4.92% |
Open: | $10.8964 |
Close: | $10.43 |
High: | $10.99 |
Low: | $10.195 |
Volume: | 336,336 |
Last Trade Date Time: | 10/28/2021 04:56:19 pm |
News | Mountain Crest Acquisition Corp. II (NASDAQ:MCAD)
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) (the “Company”), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to appro...
NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digi...
Message Board Posts | Mountain Crest Acquisition Corp. II (NASDAQ:MCAD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Mountain Crest Acquisition Corp. II Company Name:
MCAD Stock Symbol:
NASDAQ Market:
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD) (the “Company”), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to appro...
NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digi...
Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, has been invited to present at the Lake Street’s 5th Annual Best Id...